Myeloma Clinician Scientist 🔬💊👩🏻‍🔬👩🏻‍⚕️

London, England
Joined December 2012
What is ⁦@EHA_Hematology⁩ Clinical Research Training in #Hematology (CRTH)? #CRTH provides early-career researchers with a unique, 9-month long training and mentoring experience. The CRTH 2025 call for applications is open until August 30, 2024 search.app/383eipgfnc8AdXth7
4
1
17
2,424
📣 Our Early Career Advancement Fellowships are officially open for applications! 📣 These awards will support the brightest and best early career blood cancer researchers as they begin their journey to independence. Full details on our website bloodcancer.org.uk/research/…
1
9
10
2,236
.@mvmateos makes a very important point - Frailty score is dynamic! It’s important to reassess frailty- bone pain and renal impairment may change with treatment. Frailty is not one and done. #mmsm #EHA2024
5
1
14
1,178
From learning new #clinicaltrial skills to developing your own research project, #EHA Clinical Research Training in Hematology (#CRTH) is a chance to advance your #hematology career. Hear from C Lecat, past CRTH scholar about her experience 👇 Learn more: eha.fyi/CRTH25
4
12
2,220
Not sure if you can submit an abstract and join #EHA2024? If you are under 36, you may qualify for a travel or participation grant. Grant applications are available during regular abstract submission and close on March 1, 2024. Submit an abstract: eha.fyi/EHA2024_abstracts
5
1
5
2,476
Charlotte Pawlyn retweeted
Protein shake! Amazing talk by @apwiita on Proteomics to ID new MM targets. Poss source of biomarkers / classification of disease. Can use protein “Surfaceome” to ID new targets /protein conformation differences specific to MM plasma cells for targeting #mmsm #IMS23 @UCSFCancer
7
22
2,122
Charlotte Pawlyn retweeted
B cells gone Bad… aberrant B cell differentiation as the origin of MM. 1q abnormalities detectable in pt B cells —> implications for FCRL5 Congratulations to Wen Zhou for this work and #IMS23 abstract prize ! #mmsm – at Attiki, Greece
3
17
1,689
📢 On #EuropeanMyelomaDay, our goal is to highlight the crucial importance of early diagnosis for better patient outcomes. 24% of patients will wait 5 months or more to get a #myeloma diagnosis. Learn more here: mpeurope.org/2023/09/27/24-o…
1
12
1
19
2,699
Today is #EuropeanMyelomaDay! MPE launched this effort to spotlight the needs of patients like Vincent Claus and tackle issues such as delayed diagnosis. Watch the video to see how myeloma affects lives and learn how you can be part of the change. #LearnShareChange
4
1
3
1,381
Charlotte Pawlyn retweeted
Problematic Progenitors: awesome work by @Dr_Rodg showing that MM relapse may be driven by B cells & pre-plasma cells. One of my fave abstracts this am, as I am convinced that the “MM stem cell” is the 🔑 to cure #IMS23 #mmsm – at Attiki, Greece
3
3
15
1,555
Outstanding plenary talk by Dr Peter Campbell highlighting complexity of mutational burden, T cell clones and selection pressures that inform clonal heterogeneity of in cancer - we have a lot to learn still about clinical/therapeutic implications in #mmsm #IMS23 - job is not done yet.
10
48
3,633
Charlotte Pawlyn retweeted
Plenary #IMS2023 session- Dr. Nikhil Munshi summarizing advances in #myeloma field over the past few years, drug approvals and improved levels of response in highly pretreated patients, updated definition of high risk disease.
9
17
1,743
As part of #BloodCancerAwarenessMonth, MPE is raising awareness about myeloma early diagnosis. Join MPE Co-Chief Executive Officer, @KateEMor_ and the rest of the myeloma patient community on Wednesday for #EuropeanMyelomaDay. mpeurope.org/european-myelom… #LearnShareChange
5
5
449
It has been a great honor to have joined as faculty in @EHA_Hematology “Clinical Research Training in #Hematology #EHACRTH 2023. We are about to finalize the 2nd Workshop in Rome 🇮🇹 and I want to congratulate all scholars for their excellent work #mentoring #research
2
1
17
2,171
This year's cohort of #EHA Clinical Research Training in Hematology scholars have already begun the second workshop of the year. From sharing their projects to learning new approaches in clinical research. Our #EHACRTH scholars and faculty are already hard at work. eha.fyi/CRTH24 #YoungEHA
5
16
3,644
Charlotte Pawlyn retweeted
Congratulations to the haematology team at @royalmarsdenNHS who were presented with the Myeloma UK Clinical Service Excellence Programme (CSEP) Award for the second time yesterday. Recognising their commitment to raising the bar for treatment and providing compassionate care 🧡
7
13
4
88
9,757
Charlotte Pawlyn retweeted
Happy New Year! Thinking about new/next step in ur drug discovery career? We're looking (multiple levels) 4 expertise in target validation, DMPK, in vivo pharmacology, drug discovery. See lots of opportunities 2 join us in discovering new cancer medicines: jobs.icr.ac.uk/vacancies/vac…
2
7
1,756
MPE's Head of Policy and Access, @KateEMor_, is presenting the recommendations, actions and next steps that MPE has developed to improve #myelomadiagnosis. The recommendations are based on the findings of the research that has been presented today at the #EuropeanMyelomaDay
1
1
10 minutes to go!⏱️ We are about to start our online event for the first-ever #EuropeanMyelomaDay! if are not registered yet, click here! mpeurope.org/european-myelom… #LearnShareGrow
1
3
4
Charlotte Pawlyn retweeted
We're hiring! Scientific Project Manager needed to support our new Centre for Target Validation. Help us launch this key Centre that supports robust decision-making for drug discovery. Click here for details 👇 jobs.icr.ac.uk/vacancies/318…